News Sarepta files controversial Duchenne drug in EU US biotech seeks conditional approval for eteplirsen in EU.
News PTC's muscular dystrophy drug can stay on EU market - regula... But PTC must conduct further trial to confirm Translarna's benefits.
News FDA's Duchenne drug approval greeted with joy, but remains c... FDA will require efficacy evidence.
News EU pharma calls for speedy shift to digital package inserts Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
